SCHEMBL3228491

SCHEMBL3228491

COc1cc(C)cc(N)c1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.52
CYP3A4 P08684 3/20 0.52
ACHE P22303 2/20 0.48
GAA P10253 5/20 0.42
NPC1 O15118 1/20 0.42
TDP1 Q9NUW8 3/20 0.39
POLB P06746 2/20 0.39
HSD17B10 Q99714 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TSHR P16473 1/20 0.39
ADRA2B P18089 1/20 0.37
PTGS1 P23219 1/20 0.37
MAPT P10636 3/20 0.36
MEN1 O00255 1/20 0.36
THRB P10828 1/20 0.36
KMT2A Q03164 1/20 0.36
GFER P55789 1/20 0.36
ERN1 O75460 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29513975 0.78 ALDH1A1 (0.50) ALDH1A1CYP3A4GAANPC1TDP1
SCHEMBL4406554 0.78 ALDH1A1 (0.50) ALDH1A1CYP3A4GAANPC1TDP1
SCHEMBL12653027 0.78 ALDH1A1 (0.47) ALDH1A1CYP3A4GAANPC1TDP1
SCHEMBL8761590 0.77 ACHE (0.52) ALDH1A1CYP3A4ACHEL3MBTL1MAPT
SCHEMBL8056786 0.77 ACHE (0.52) ALDH1A1CYP3A4ACHEGAAPOLB
SCHEMBL16372539 0.77 ALDH1A1 (0.56) ALDH1A1CYP3A4ACHEGAANPC1
SCHEMBL4730926 0.77 ALDH1A1 (0.56) ALDH1A1CYP3A4ACHEGAANPC1
SCHEMBL23702702 0.77 POLB (0.47) ALDH1A1CYP3A4GAANPC1TDP1
SCHEMBL4407650 0.77 CYP3A4 (0.50) ALDH1A1CYP3A4GAANPC1TDP1
SCHEMBL16134103 0.75 POLB (0.46) ALDH1A1CYP3A4ACHEGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO disclosed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed